Skip to main content

Advertisement

SpringerLink
Log in

Macrophage activation syndrome in juvenile dermatomyositis: a systematic review

  • Systematic Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Macrophage activation syndrome (MAS) is a potentially fatal complication of a number of rheumatological conditions, but few studies assessed it in juvenile dermatomyositis (JDM). Indeed, MAS is not considered as a frequent complication of JDM, but its occurrence could be under-estimated. In order to address this issue, we performed a revision of the available medical literature, describing and assessing patients with both MAS and JDM. After retrieving 253 records initially, 11 papers were selected as appropriate for our research objective, which provided a total of 12 patients affected with both MAS and JDM. Our pooled case series suggested that MAS in JDM may not be very rare, even though no final conclusion about its incidence and mortality rate can be made. However, JDM-related MAS seems to be difficult to treat, since methylprednisolone pulse therapy alone was not sufficient in most cases. Moreover, MAS in JDM patients often occurred at the onset of the rheumatic disease, before the final diagnosis of JDM could be established. Finally, MAS criteria validated for systemic Juvenile Idiopathic Arthritis (sJIA) resulted to be a very useful guidance to diagnose MAS in JDM patients as well, but their reliability may not be absolute. Therefore, cohort and multicenter studies are needed to assess the incidence and improve the diagnostic criteria for MAS in JDM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bracaglia C, Prencipe G, De Benedetti F (2017) Macrophage activation syndrome: different mechanisms leading to a one clinical syndrome. Pediatr Rheumatol Online J 15(1):5. https://doi.org/10.1186/s12969-016-0130-4

    Article  PubMed  PubMed Central  Google Scholar 

  2. Cron RQ, Davi S, Minoia F, Ravelli A (2015) Clinical features and correct diagnosis of macrophage activation syndrome. Expert Rev Clin Immunol 11(9):1043–1053. https://doi.org/10.1586/1744666x.2015.1058159

    Article  CAS  PubMed  Google Scholar 

  3. Lerkvaleekul B, Vilaiyuk S (2018) Macrophage activation syndrome: early diagnosis is key. Open Access Rheumatol 10:117–128. https://doi.org/10.2147/oarrr.s151013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Henter JI, Horne A, Aricó M, Egeler RM et al (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124–311. https://doi.org/10.1002/pbc.21039

    Article  PubMed  Google Scholar 

  5. Ravelli A, Minoia F, Davì S, Paediatric Rheumatology International Trials Organisation, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology Collaborative Study Group, Histiocyte Society et al (2016) 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation collaborative initiative. Arthritis Rheumatol 68(3):566–576. https://doi.org/10.1136/annrheumdis-2015-208982

    Article  CAS  PubMed  Google Scholar 

  6. Behrens EM, Beukelman T, Paessler M, Cron RQ (2007) Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 34(5):1133–1138

    PubMed  Google Scholar 

  7. Huber AM (2018) Update on the clinical management of juvenile dermatomyositis. Expert Rev Clin Immunol 14(12):1021–1028. https://doi.org/10.1080/1744666x.2018.1535901

    Article  CAS  PubMed  Google Scholar 

  8. Huber AM (2018) Juvenile idiopathic inflammatory myopathies. Pediatr Clin N Am 65(4):739–756. https://doi.org/10.1016/j.pcl.2018.04.006

    Article  Google Scholar 

  9. Poddighe D, Mukusheva Z, Assylbekova M (2019) Pruritus in patients with amyopathic dermatomyositis. Allergy Asthma Clin Immunol 15:18. https://doi.org/10.1186/s13223-019-0334-5

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kobayashi I, Yamada M, Kawamura N, Kobayashi R, Okano M, Kobayashi K (2000) Platelet-specific hemophagocytosis in a patient with juvenile dermatomyositis. Acta Paediatr 89(5):617–619. https://doi.org/10.1080/080352500750027989

    Article  CAS  PubMed  Google Scholar 

  11. Sterba G, Rodriguez C, Sifontes S, Vigilanza P (2004) Macrophage activation syndrome due to methotrexate in a 12-year-old boy with dermatomyositis. J Rheumatol 31(5):1014–1015

    PubMed  Google Scholar 

  12. Kobayashi I, Kawamura N, Okano M et al (2006) Thrombocytopaenia in juvenile dermatomyositis. Scand J Rheumatol 35(1):79–80. https://doi.org/10.1080/03009740510018642

    Article  CAS  PubMed  Google Scholar 

  13. Yajima N, Wakabayashi K, Odai T et al (2008) Clinical features of hemophagocytic syndrome in patients with dermatomyositis. J Rheumatol 35(9):1838–1841

    PubMed  Google Scholar 

  14. Bustos R, Carrasco C, Toledo C (2012) Plasmaféresis en el síndrome de activación macrofágica y fracaso multiorgánico como primera manifestación de una dermatomyositis juvenile. An Pediatr 77(1):47–50. https://doi.org/10.1016/j.anpedi.2011.12.011

    Article  CAS  Google Scholar 

  15. Yamashita H, Matsuki Y, Shimizu A et al (2013) Hemophagocytic lymphohistiocytosis complicated by central nervous system lesions in a patient with dermatomyositis: a case presentation and literature review. Mod Rheumatol 23(2):386–932. https://doi.org/10.1007/s10165-012-0661-6

    Article  PubMed  Google Scholar 

  16. Lilleby V, Haydon J, Sanner H, Krossness BK, Ringstad G, Flatø B (2014) Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis. Scand J Rheumatol 43(2):171–173. https://doi.org/10.3109/03009742.2013.863968

    Article  CAS  PubMed  Google Scholar 

  17. Poddighe D, Cavagna L, Brazzelli V, Bruni P, Marseglia GL (2014) A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria. Autoimmun Rev 13(11):1142–1148. https://doi.org/10.1016/j.autrev.2014.05.009

    Article  CAS  PubMed  Google Scholar 

  18. Wakiguchi H, Hasegawa S, Hirano R, Kaneyasu H, Wakabayashi-Takahara M, Ohga S (2015) Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels. Pediatr Rheumatol Online J 13:49. https://doi.org/10.1186/s12969-015-0048-2

    Article  PubMed  PubMed Central  Google Scholar 

  19. Onen SS, Umit Z, Onder Sivis Z et al (2014) Juvenile dermatomyositis with a rare and severe complication: macrophage activation syndrome. J Pediatr Res 1(4):218–221. https://doi.org/10.4274/jpr.53825

    Article  Google Scholar 

  20. Deschamps R, Couture J, Hadjinicolaou A, LeBlanc CMA (2018) A 17-year-old girl with facial edema and weakness. Paediatr Child Health 23(4):241–244. https://doi.org/10.1093/pch/pxx209

    Article  PubMed  PubMed Central  Google Scholar 

  21. Davì S, Minoia F, Pistorio A, Paediatric Rheumatology International Trials Organisation, The Childhood Arthritis and Rheumatology Research Alliance, The Pediatric Rheumatology Collaborative Study Group, The Histiocyte Society et al (2014) Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol 66(10):2871–2880. https://doi.org/10.1002/art.38769

    Article  CAS  PubMed  Google Scholar 

  22. Parodi A, Davì S, Pringe AB, Lupus Working Group of the Paediatric Rheumatology European Society et al (2009) Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 60(11):3388–3399. https://doi.org/10.1002/art.24883

    Article  CAS  PubMed  Google Scholar 

  23. Wang W, Gong F, Zhu W, Fu S, Zhang Q (2015) Macrophage activation syndrome in Kawasaki disease: more common than we thought? Semin Arthritis Rheum 44(4):405–410. https://doi.org/10.1016/j.semarthrit.2014.07.007

    Article  CAS  PubMed  Google Scholar 

  24. Rider LG, Lindsley CB, Miller FW (2016) Juvenile dermatomyositis. Textbook of pediatric rheumatology, 7th edn. Elsevier, Philadelphia, pp 351–373

    Chapter  Google Scholar 

  25. De Benedetti F, Schneider R (2016) Systemic juvenile idiopathic arthritis. Textbook of pediatric rheumatology, 7th edn. Elsevier, Philadelphia, pp 205–216

    Chapter  Google Scholar 

  26. Klein-Gitelman M, Lane GC (2016) Systemic lupus erythematosus. Textbook of pediatric rheumatology, 7th edn. Elsevier, Philadelphia, pp 285–313

    Chapter  Google Scholar 

  27. Son MB, Sundel RP (2016) Kawasaki disease. Textbook of pediatric rheumatology, 7th edn. Elsevier, Philadelphia, pp 467–482

    Chapter  Google Scholar 

  28. García-Pavón S, Yamazaki-Nakashimada MA, Báez M, Borjas-Aguilar KL, Murata C (2017) Kawasaki disease complicated with macrophage activation syndrome: a systematic review. J Pediatr Hematol Oncol 39(6):445–451. https://doi.org/10.1097/mph.0000000000000872

    Article  PubMed  Google Scholar 

  29. Grom AA (2016) Macrophage activation syndrome. Textbook of pediatric rheumatology, 7th edn. Elsevier, Philadelphia, pp 642–648

    Chapter  Google Scholar 

  30. Minoia F, Davì S, Horne A, Pediatric Rheumatology International Trials Organization, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology Collaborative Study Group, Histiocyte Society et al (2015) Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Rheumatol 42(6):994–1001. https://doi.org/10.3899/jrheum.141261

    Article  PubMed  Google Scholar 

  31. Poddighe D, Romano M, Gattinara M, Gerloni V (2018) Biologics for the treatment of juvenile idiopathic arthritis. Curr Med Chem 25(42):5860–5893. https://doi.org/10.2174/0929867325666180522085716

    Article  CAS  PubMed  Google Scholar 

  32. Minoia F, Bovis F, Davì S, Horne A et al (2019) Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2019-215211(Epub ahead of print)

    Article  PubMed  Google Scholar 

  33. Kelly A, Ramanan AV (2017) Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol 9(5):477–481. https://doi.org/10.1097/bor.0b013e32825a6a79

    Article  Google Scholar 

  34. Ravelli A, Minoia F, Davì S et al (2016) Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. RMD Open 2(1):e000161. https://doi.org/10.1136/rmdopen-2015-000161

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, School of Medicine, Nazarbayev University, Kerei-Zhanibek Str. 5/1, Nur-Sultan, 010000, Kazakhstan

    Dimitri Poddighe & Kaisar Dauyey

Authors
  1. Dimitri Poddighe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kaisar Dauyey
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

DP conceived the study; DP and KD performed the literature search and wrote the article.

Corresponding author

Correspondence to Dimitri Poddighe.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Poddighe, D., Dauyey, K. Macrophage activation syndrome in juvenile dermatomyositis: a systematic review. Rheumatol Int 40, 695–702 (2020). https://doi.org/10.1007/s00296-019-04442-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-019-04442-1

Keywords

Search

Navigation